PattleR. E., and ThomasL. C.: Lipoprotein composition of the film lining the lung, Nature, 1961, 189, 844.
6.
BuckinghamS.: Studies on the identification of an antiatelectasis factor in normal sheep lung, Am J Dis Child, 1961, 102, 521–522.
7.
KlausM. H., ClementsJ. A., and HavelR. J.: Composition of surface-active material isolated from beef lung, Proc Natl Acad Sci USA, 1961, 47, 1858–1859.
8.
BondurantS., and MillerD. A.: A method for producing surface-active extracts of mammalian lungs, J Appl Physiol, 1962, 17, 167–168.
9.
BrownE. S.: Isolation and assay of dipalmityl lecithin in lung extracts, Am J Physiol, 1964, 207, 402–406.
10.
ThannhauserS. J., BenottiJ., and BoncoddoN. F.: Isolation and properties of hydrolecithin (dipalmityl lecithin) from lung, its occurrence in the sphingomyelin fraction of animal tissues, J Biol Chem, 1946, 166, 669–75.
11.
LeathesJ. B.: Role of fats in vital phenomena, Lancet, 1925, 1, 853–56.
12.
KingR. J.: The surfactant system of the lung, Fed Proc, 1974, 33, 2232–2237.
13.
ClementsJ. A., and KingR. J.: Composition of the surface active material, in The Biochemical Basis of Pulmonary Function, CrystalR. G., ed., Marcel Dekker, New York, 1976, pp. 363–387.
14.
The Biochemical Basis of Pulmonary Function, CrystalR. G., ed., Marcel Dekker, New York, 1976.
LowF. N.: The electron microscopy of sectioned lung tissue after varied duration of fixation in buffered osmium tetroxide, Anat Rec, 1954, 120, 827–851.
WoodsideG. L., and DaltonA. J.: The ultrastructure of lung tissue from newborn and embryo mice, J Ultrastruct Res, 1958, 2, 28–54.
19.
BuckinghamS., and AveryM. E.: Time of appearance of lung surfactant in the foetal mouse, Nature, 1962, 193, 688–689.
20.
KlausM., ReissO. K., TooleyW. H., PielC., and ClementsJ. A.: Alveolar epithelial cell mitochondria as source of the surface-active lung lining, Science, 1962, 137, 750–751.
21.
CampicheM.: Remarques sur l'ultrastructure des inclusions lamellaires de l'épithélium pulmonaire, Rev Méd Suisse Romande, 1965, 85, 532–536.
22.
GilJ., and ReissO. K.: Isolation and characterization of lamellar bodies and tubular myelin from rat lung homogenates, J Cell Biol, 1973, 58, 152–171.
23.
WilliamsM. C., and MasonR. J.: Development of the type II cell in the fetal rat lung, Am Rev Respir Dis, 1977, 115 (Supplement, pp. 37–47).
24.
WilliamsM. C.: Conversion of lamellar body membranes into tubular myelin in alveoli of fetal rat lungs, J Cell Biol, 1977, 72, 260–277.
25.
CampicheM. A., GautierA., HernandezE. I., and ReymondA.: An electron microscope study of the fetal development of human lung, Pediatrics, 1963, 32, 976–994.
26.
MeneesT. O., MillerJ. D., and HollyL. E.: Amniography: Preliminary report, Am J Roentgenol, 1930, 24, 363–366.
27.
CantarowA., StuckertH., and DavisR. C.: The chemical composition of amniotic fluid, Surg Gynecol Obstet, 1933, 57, 63–70.
28.
PreyerW.: Specielle Physiologie des Embryo, Grieben, Leipzig, 1885, p. 148.
29.
JostA., and PolicardA.: Contribution expérimentale à l'étude du développement prénatal du poumon chez le lapin, Arch Anat Microsc, 1948, 37, 323–332.
30.
SetnikarI., AgostoniE., and TagliettiA.: The fetal lung, a source of amniotic fluid, Proc Soc Exp Biol Med, 1959, 101, 842–845.
31.
AdamsF. H., FujiwaraT., and RowshanG.: The nature and origin of the fluid in the fetal lamb lung, J Pediatr, 1963, 63, 881–888.
32.
AdamsF. H., and FujiwaraT.: Surfactant in fetal lamb tracheal fluid, J Pediatr, 1963, 63, 537–542.
33.
FujiwaraT., AdamsF. H., and ScudderA.: Fetal lamb amniotic fluid: Relationship of lipid composition to surface tension, J Pediatr, 1964, 65, 824–830.
34.
ScarpelliE. M.: The lung, tracheal fluid, and lipid metabolism of the fetus, Pediatrics, 1967, 40, 951–961.
35.
AdamsF. H., DesiletsD. T., and TowersB.: Control of flow of fetal lung fluid at the laryngeal outlet, Respir Physiol, 1967, 2, 302–309.
36.
HowattW. F., HumphreysP. W., NormandI. C. S., and StrangL. B.: Ventilation of liquid by the fetal lamb during asphyxia, J Appl Physiol, 1965, 20, 496–502.
37.
AdamsonT. M., BoydR. D. H., PlattH. S., and StrangL. B.: Composition of alveolar liquid in the foetal lamb, J Physiol, 1969, 204, 159–168.
38.
GluckL., KulovichM. V., and BorerR. C.Jr.: Diagnosis of the respiratory distress syndrome by amniocentesis, Am J Obstet Gynecol, 1971, 109, 440–445.
39.
ClementsJ. A., PlatzkerA. C. G., TierneyD. F., HobelC. J., CreasyR. K., MargolisA. J., ThibeaultD. W., TooleyW. H., and OhW.: Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid, N Engl J Med, 1972, 286, 1077–1081.
40.
EvansJ. J.: Prediction of respiratory-distress syndrome by shake test on newborn gastric aspirate, N Engl J Med, 1975, 292, 1113–1115.
41.
LigginsG. C.: Premature delivery of foetal lambs infused with glucocorticoids, J Endocrinol, 1969, 45, 515–523.
42.
MescherE. J., PlatzkerA. C. G., BallardP. L., KittermanJ. A., ClementsJ. A. and TooleyW. H.: Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb, J Appl Physiol, 1975, 39, 1017–1021.
43.
AveryM. E.: Pharmacological approaches to the acceleration of fetal lung maturation, Br Med Bull, 1975, 31, 13–17.
44.
FarrellP. M., and AveryM. E.: Hyaline membrane disease, Am Rev Respir Dis, 1975, 111, 657–688.
45.
de LemosR. A., ShermetaD. W., KnelsonJ. H., KotasR., and AveryM. E.: Acceleration of appearance of pulmonary surfactant in the fetal lamb by administration of corticosteroids, Am Rev Respir Dis, 1970, 102, 459–461.
46.
WangN. S., KotasR. V., AveryM. E., and ThurlbeckW. M.: Accelerated appearance of osmiophilic bodies in fetal lungs following steroid injection, J Appl Physiol, 1971, 30, 362–365.
47.
KotasR. V., and AveryM. E.: Accelerated appearance of pulmonary surfactant in the fetal rabbit, J Appl Physiol, 1971, 30, 358–361.
48.
LigginsG. C., and HowieR. N.: A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants, Pediatrics, 1972, 50, 515–525.
49.
Lung Maturation and the Prevention of Hyaline Membrane Disease, Proceedings of the Seventieth Ross Conference on Pediatric Research, December 7-10, 1975, Columbus, Ohio, Ross Laboratories, 1976.
50.
ProvenzanoR. W.: Adrenocortical hypoplasia in the newborn infant: Report of a case with replacement therapy, N Engl J Med., 1950, 242, 87–89.
51.
ProvenzanoR. W., McGovernP., SchultzR., and HesterJ.: Adrenal cortex extract in pediatrics, Am J Dis Child, 1951, 81, 323–328.
52.
BuckinghamS., McNaryW. F., SommersS. C., and RothschildJ.: Is lung an analog of Moog's developing intestine? I. Phosphatases and pulmonary alveolar differentiation in fetal rabbits, Fed Proc, 1968, 27, 328.
53.
SwyerP. R.: An assessment of artificial respiration in the newborn, in Problems of Neonatal Intensive Care Units, Report of the Fifty-Ninth Ross Conference on Pediatric Research, Columbus, Ohio, Ross Laboratories, 1969, pp. 25–35.
54.
GregoryG. A., KittermanJ. A., PhibbsR. H., TooleyW. H., and HamiltonW. K.: Continuous positive airway pressure with spontaneous respiration: A new method of increasing arterial oxygenation in the respiratory distress syndrome, Pediatr Res, 1970, 4, 469–470.
55.
GregoryG. A., KittermanJ. A., PhibbsR. H., TooleyW. H., and HamiltonW. K.: Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure, N Engl J Med, 1971, 284, 1332–1340.
56.
Putting pressure on hyaline, Med World News, Jan 14, 1972, 27, 32.
57.
AveryM. E., and MeadJ.: Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child, 1959, 97, 517–523.
AuldP. A. M., KraussA. N., and KlainD. B.: Continuous positive airway pressure (letter to the editor), Pediatrics, 1972, 49, 468–469.
60.
RobillardE., AlarieY., Dagenais-PerusseP., BarilE., and GuilbeaultA.: Microaerosol administration of synthetic β-y-dipalmitoyl-L-a-lecithin in the respiratory distress syndrome: A preliminary report, Can Med Assoc J, 1964, 90, 55–57.
61.
ChuJ., ClementsJ. A., CottonE. K., KlausM. H., SweetA. Y., and TooleyW. H.: Neonatal pulmonary ischemia. Part I: Clinical and physiological studies, Pediatrics, 1967, 40, 709–782.
62.
FinleyT. N., TooleyW. H., SwensonE. W., GardnerR. E., and ClementsJ. A.: Pulmonary surface tension in experimental atelectasis, Am Rev Respir Dis, 1964, 89, 372–378.
63.
CournandA., MotleyH. L., WerköL., and RichardsD. W.Jr.: Physiological studies of the effects of intermittent positive pressure breathing on cardiac output in man, Am J Physiol, 1948, 152, 162–174.
64.
WerköL.: The influence of positive pressure breathing on the circulation in man, Acta Med Scand128, Suppl. 193, 125 pp.
65.
BeecherH. K., BennettH. S., and BassettD. L.: Circulatory effects of increased pressure in the airway, Anesthesiology, 1943, 4, 612–618.
66.
OtisA. B., RahnH., and FennW. O.: Venous pressure changes associated with positive intrapulmonary pressures; their relationship to the distensibility of the lung, Am J Physiol, 1946, 146, 307–317.
67.
PriceH. L., KingB. D., ElderJ. D., LibienB. H., and DrippsR. D.: Circulatory effects of raised airway pressure during cyclopropane anesthesia in man, J Clin Invest, 1951, 30, 1243–1249.
68.
HermanS., and ReynoldsE. O. R.: Methods for improving oxygenation in infants mechanically ventilated for severe hyaline membrane disease, Arch Dis Child, 1973, 48, 612–617.
69.
TooleyW. H., GardnerR. E., HamiltonW. K., MaddisonF. E., MarkelG. G., WrightR. R., and BradleyB. L.: Unpublished observations, 1962.
70.
TooleyW. H.: Hyaline membrane disease—Telling it like it was, Am Rev Respir Dis, 1977, 115 (Supplement, pp. 19–28).
71.
HarrisonV. C., HeeseH. de V., and KleinM.: The significance of grunting in hyaline membrane disease, Pediatrics, 1968, 41, 549–559.
72.
SmithP. C., DailyW. J. R., FletcherG., MeyerH. B. P., and TaylorG.: Mechanical ventilation of newborn infants. I. The effect of rate and pressure on arterial oxygenation of infants with respiratory distress syndrome, Pediatr Res, 1969, 3, 244–254.
73.
LlewellynM. A., and SwyerP. R.: Positive expiratory pressure during mechanical ventilation of the newborn, in Program of the Society for Pediatric Research, Atlantic City, New Jersey, 1970, p. 224.
74.
WeinsteinM. C.: Allocation of subjects in medical experiments, N Engl J Med, 1974, 291, 1278–1285.
75.
GehanE. A., and FreireichE. J.: Non-randomized controls in cancer clinical trials, N Engl J Med., 1974, 290, 198–203.
76.
ChalmersT. C.: Randomization of the first patient, Med Clin North Am, 1975, 59, 1035–1038.
77.
SilvermanW. A.: The lesson of retrolental fibroplasia, Sci Am, 1977, 236 (6), 100–107.
78.
ByarD. P., SimonR. M., FriedewaldW. T., SchlesselmanJ. J., DeMetsD. L., EllenbergJ. H., GailM. H., and WareJ. H.: Randomized clinical trials, perspectives on some recent ideas, N Engl J Med, 1976, 295, 74–80.
79.
HillA. B.: The clinical trial, Br Med Bull, 1951, 7, 278–282.
80.
ReynoldsE. O. R.: Management of hyaline membrane disease, Br Med Bull, 1975, 31, 18–24.
81.
CalderR.: Profile of Science, George Allen & Unwin, London, 1951.
82.
ScarpelliE. M.: The Surfactant System of the Lung, Lea & Febiger, Philadelphia, 1968.
83.
Respiratory Diseases, Task Force Report on Prevention, Control, Education, Division of Lung Diseases, National Heart, Lung and Blood Institute, Washington, D.C., DHEW Publication No. (NIH) 77-1248, March1977.
84.
BoysC. V.: Soap-Bubbles, Their Colours and the Forces which Mould Them, Society for Promoting Christian Knowledge, London, 1890; ed. 2, 1911, reprinted by Dover Publications, New York, 1959.